• LAST PRICE
    20.4600
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    20.1700/ 10
  • Ask / Lots
    20.7700/ 10
  • Open / Previous Close
    --- / 20.4600
  • Day Range
    ---
  • 52 Week Range
    Low 15.3100
    High 26.8400
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 19.76
TimeVolumeXNCR
09:32 ET1013420.18
09:34 ET80019.88
09:36 ET192420.1
09:38 ET20020.1
09:39 ET30020.135
09:41 ET157720.14
09:43 ET221820.245
09:45 ET161620.1612
09:48 ET153220.2
09:50 ET30020.245
09:52 ET158620.27
09:54 ET100020.095
09:56 ET40020.11
09:57 ET30020.125
09:59 ET10020.125
10:01 ET326520.37
10:03 ET65020.33
10:06 ET117320.4
10:08 ET40020.29
10:10 ET30020.33
10:12 ET10020.335
10:14 ET30020.37
10:15 ET110020.34
10:17 ET20020.37
10:19 ET70520.355
10:21 ET10020.355
10:26 ET98020.32
10:28 ET10020.35
10:30 ET20020.36
10:32 ET10020.29
10:33 ET10020.34
10:35 ET35020.41
10:37 ET10020.41
10:39 ET30020.39
10:42 ET110020.38
10:44 ET10020.39
10:46 ET30020.36
10:48 ET60520.41
10:53 ET10020.4
10:55 ET60020.375
10:57 ET10020.295
11:00 ET10020.27
11:06 ET116120.18
11:09 ET70020.33
11:11 ET20020.32
11:13 ET19620.305
11:15 ET10020.29
11:18 ET26520.34
11:20 ET10020.33
11:22 ET10020.36
11:26 ET10020.36
11:27 ET88620.33
11:31 ET40020.335
11:33 ET10020.33
11:40 ET50020.32
11:42 ET10020.31
11:44 ET10020.31
11:47 ET70020.35
11:49 ET10020.345
11:51 ET70020.325
11:56 ET51520.34
11:58 ET41220.3652
12:00 ET43320.38
12:02 ET20020.415
12:03 ET10020.425
12:05 ET80020.4
12:09 ET40020.42
12:12 ET39920.405
12:14 ET120020.4025
12:16 ET60020.37
12:18 ET10020.375
12:21 ET30020.38
12:23 ET192020.41
12:25 ET10020.42
12:27 ET342820.505
12:30 ET40020.495
12:32 ET64220.495
12:34 ET10020.52
12:38 ET284520.58
12:41 ET30020.575
12:43 ET60020.584
12:45 ET10020.59
12:48 ET30020.62
12:52 ET20020.59
12:54 ET20020.6
12:56 ET50020.595
12:57 ET30020.625
12:59 ET227820.6
01:01 ET196620.59
01:03 ET100020.56
01:06 ET170020.53
01:08 ET64820.535
01:12 ET90020.525
01:14 ET10020.515
01:17 ET70020.515
01:19 ET90020.5125
01:21 ET10020.49
01:24 ET10020.5
01:26 ET120020.49
01:28 ET150020.42
01:30 ET130020.425
01:32 ET171020.49
01:33 ET120020.395
01:35 ET10020.405
01:37 ET25020.37
01:39 ET40020.41
01:42 ET146520.405
01:46 ET60020.435
01:50 ET10020.42
01:51 ET10020.435
01:55 ET40020.45
01:57 ET10020.4
02:00 ET60020.435
02:04 ET198020.46
02:08 ET10020.42
02:09 ET73420.426
02:11 ET30020.42
02:15 ET90020.47
02:20 ET10020.49
02:22 ET20020.495
02:26 ET10020.51
02:29 ET30020.48
02:31 ET20020.47
02:36 ET10020.475
02:38 ET28520.465
02:40 ET82820.5
02:42 ET78020.5
02:44 ET190020.55
02:47 ET35420.525
02:51 ET68220.535
02:54 ET80020.52
02:56 ET417420.6
02:58 ET42620.57
03:00 ET97420.57
03:02 ET70020.565
03:03 ET43220.58
03:05 ET100020.62
03:09 ET40020.645
03:12 ET10020.645
03:14 ET161220.68
03:16 ET10020.685
03:18 ET105020.655
03:20 ET54720.64
03:21 ET290920.65
03:23 ET30020.64
03:25 ET50020.64
03:27 ET40020.65
03:30 ET69920.62
03:32 ET10020.6
03:34 ET230020.56
03:36 ET1110020.56
03:38 ET389820.58
03:39 ET120020.6
03:41 ET993920.58
03:43 ET180520.61
03:45 ET30020.595
03:48 ET173020.595
03:50 ET60020.58
03:52 ET260020.55
03:54 ET130020.55
03:56 ET921820.34
03:57 ET1197920.48
03:59 ET10598620.46
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesXNCR
Xencor Inc
1.4B
-7.1x
---
United StatesARDX
Ardelyx Inc
1.5B
-22.8x
---
United StatesRCUS
Arcus Biosciences Inc
1.4B
-5.0x
---
United StatesDVAX
Dynavax Technologies Corp
1.4B
107.3x
---
United StatesTVTX
Travere Therapeutics Inc
1.2B
-3.0x
---
United StatesAUPH
Aurinia Pharmaceuticals Inc
1.0B
-20.4x
---
As of 2024-09-27

Company Information

Xencor, Inc. is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases. More than 20 candidates engineered with its XmAb technology are in clinical development, and three XmAb medicines are marketed by partners. Its XmAb engineering technology enables small changes to a protein structure that result in new mechanisms of therapeutic action. Its wholly owned development candidates include Vudalimab, XmAb819, XmAb808, and XmAb541. Candidates co-developed with partners include Plamotamab. Candidates advanced by partners include Xaluritamig (AMG 509), ASP2138, JNJ-9401, JNJ-1493, and Novartis XmAb undisclosed antibody candidate. Its cytokine drug candidates in clinical development consist of fbalropendekin alfa (XmAb306/RG6323), XmAb564, and XmAb662. Its other clinical-stage drug candidates consist of Obexelimab, AIMab7195 (XmAb7195), and Xpro1595. Vudalimab is a bispecific antibody that targets PD-1 and CTLA-4.

Contact Information

Headquarters
465 N. HALSTEAD ST., SUITE 200PASADENA, CA, United States 91107
Phone
626-305-5900
Fax
626-305-0350

Executives

President, Chief Executive Officer, Founder and Director
Bassil Dahiyat
Senior Vice President, Chief Financial Officer
Bart Cornelissen
Executive Vice President - Research, Chief Scientific Officer
John Desjarlais
Executive Vice President, Chief Development Officer
Nancy Valente
Senior Vice President, General Counsel, Corporate Secretary
Celia Eckert

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.4B
Revenue (TTM)
$133.6M
Shares Outstanding
69.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.66
EPS
$-2.90
Book Value
$10.96
P/E Ratio
-7.1x
Price/Sales (TTM)
10.7
Price/Cash Flow (TTM)
---
Operating Margin
-145.10%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.